Respiratory Distress Syndrome

Black premature newborns continue to experience higher rates of certain complications after delivery compared with white premature newborns, despite no differences in mortality rates, data show.

Women with mild chronic hypertension induced at 37 weeks’ gestation saw no reduction in adverse maternal outcomes compared with women delivered at 39 weeks, but did experience increases in some neonatal complications, data show.

Infants born to mothers vaccinated against COVID-19 during the omicron wave had decreased risks for preterm birth and adverse neonatal outcomes, according to results of the INTERCOVID-2022 study.

Among patients who died of acute respiratory distress syndrome associated with SARS-CoV-2, the virus that causes COVID-19, heart tissues were damaged even when they were not directly affected by the virus, researchers reported.

Among new nurses, receipt of virtual reality-based training vs. usual orientation led to more correct identification of respiratory distress in pediatric patients, according to results published in American Journal of Critical Care.

Elevated exposure to fine particulate matter during pregnancy raised the likelihood for assisted ventilation and systemic antibiotics among term newborns, according to results published in Environmental Health Perspectives.

Minimally invasive surfactant therapy did not reduce a composite outcome of death and neurodevelopmental disability before age 2 years among preterm infants with respiratory distress syndrome who are on continuous positive airway pressure.

The FDA has designated Draeger Medical’s recall of the Seattle-Positive Airway Pressure Plus system as a class I recall, the most serious kind.

A model featuring 13 potential predictors of acute respiratory distress syndrome was found to have “good predictive ability” in patients with sepsis, according to study results published in BMC Pulmonary Medicine.

IV administration of the beta-blocker metoprolol in patients with COVID-19-associated acute respiratory distress syndrome was safe and effective at reducing exacerbated lung inflammation, according to new data.